Results 71 to 80 of about 201,486 (315)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Left atrial function in uraemic patients: Four‐dimensional automatic left atrial quantitative technology study

ESC Heart Failure, Volume 12, Issue 2, Page 1316-1325, April 2025.
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley   +1 more source

Evaluating the reliability and validity of the geriatric assessment of disability scale in older adults undergoing hemodialysis

BMC Geriatrics
Background Nearly 50% of patients undergoing maintenance hemodialysis are aged ≥ 60 years, highlighting a growing population with unique health challenges.
Jia Wanning, He Wenwen, Yang Liu, Lu Haitao, Wang Haifeng, Dong Wan   +5 more
doaj   +1 more source

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source

Association of Optimized Nursing Care with Clinical and Patient-Reported Outcomes in Maintenance Hemodialysis Patients: A Retrospective Before-After Study

Patient Preference and Adherence
Hongmei Zhao, Changgeng Liu, Lin Song, Weihui WangHemodialysis Department, People’s Hospital of Aba Tibetan and Qiang Autonomous Prefecture, Aba, Sichuan, People’s Republic of ChinaCorrespondence: Weihui Wang, Hemodialysis Department, People’s Hospital ...
Zhao H, Liu C, Song L, Wang W
doaj  

Effect of phosphate binders on oxidative stress and inflammation markers in hemodialysis patients

, 2009
It has been suggested that phosphate binders may reduce the inflammatory state of hemodialysis (HD) patients. However, it is not clear whether it has any effect on oxidative stress.
MANFREDI, Silvia R., CARVALHO, Jose Tarcisio G., Guimaraes, Nadia [UNIFESP], Cuppari, Lilian [UNIFESP], BATISTA, Marcelo C., CENDOROGLO, Miguel, CUPPARI, Lilian, Cendoroglo Neto, Miguel [UNIFESP], Batista, Marcelo C. [UNIFESP], DRAIBE, Sergio A., Canziani, Maria E. [UNIFESP], GUIMARAES, Nadia, Carvalho, Aluisio B. [UNIFESP], CANZIANI, Maria E., Peres, Aline T. [UNIFESP], CARVALHO, Aluisio B., DALBONI, Maria A., Draibe, Sergio A. [UNIFESP], Manfredi, Silvia R. [UNIFESP], Andreoli, Maria C. [UNIFESP], Dalboni, Maria Aparecida [UNIFESP], ANDREOLI, Maria C., PERES, Aline T., Carvalho, José Tarcisio Giffoni de [UNIFESP], Jorgetti, Vanda, Moyses, Rosa M. A., Silvia R. MANFREDI, Maria A. DALBONI, Sergio A. DRAIBE, Rosa M. A. MOYSES, Jose Tarcisio G. CARVALHO, Aline T. PERES, Lilian CUPPARI, Miguel CENDOROGLO, Aluisio B. CARVALHO, Maria C. ANDREOLI, Vanda JORGETTI, Maria E. CANZIANI, Marcelo C. BATISTA, Nadia GUIMARÃES   +39 more
core   +1 more source

POS-699 BORDERLINE REJECTION AMONG KIDNEY TRANSPLANT RECIPIENTS: WHERE DOES THE TREATMENT STAND

Kidney International Reports, 2021
M. MOJAAT, M. Ben salem, I. Chemli, M. Hamouda, I. Handous, M. Ben salah, A. Letaief, S. Aloui, H. Skhiri   +8 more
doaj   +1 more source

Bioinformatics reveals TNFAIP6 as a candidate gene and suggests its potential crosstalk in the treatment of hemodialysis in chronic kidney disease

Renal Failure
Hemodialysis (HD) is a life-sustaining treatment for chronic kidney disease (CKD) patients. This study aimed to identify candidate diagnostic biomarkers associated with HD-treated CKD.
Guoxin Zhang, Jieqiong Fu, Wenming Niu
doaj   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

Epilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

The Risk Factors of Hypotension in Patients with End-Stage Chronic Glomerulonephritis During Maintenance Hemodialysis

International Journal of General Medicine
Qiaoxia Chen, Juanjuan Chen, Yanjuan Teng Department of Nursing, Shanghai Sixth People’s Hospital, Shanghai, 200233, People’s Republic of ChinaCorrespondence: Yanjuan Teng, Department of Nursing, Shanghai Sixth People’s Hospital, 600 Yishan Road ...
Chen Q, Chen J, Teng Y
doaj